RE: Staggering potential revenue9 May 2021 09:59
The future is bright with DVRG. At present MCAP this company represents an amazing investment opportunity. Regarding the end goal, and potential sale, i dont think the company as is would be sold. I think that any would-be-buyer would either want labskin/skin trust OR pathogen detection/water monitoring.
There is also the data we already have and the data we will acquire from skin trust. That data is valuable and i can see DVRG selling that off to recognise maximum value PRIOR to selling either of the components.
It is possible that DVRG will spin off the components of the company ORPH style so that each component has its own dedicated management team.
It's very early days, but i see the company being sold in the future, but hopefully for a lot more than £300m. We could see that MCAP in the not too distant future should the chinese JV, skin trust and PD/BT take off, capturing the imagination of investors, both PI and institutional.
We may well be at the early stages of DVRG becoming THE water monitoring company. The pandemic has highlighted the need for waste water monitoring and we are almost ready to give the governments what they want. JV, like the one in China, will be necessary as there is no way little old DVRG (as it is at present), could possibly manufacture at the scale required. But many JV's on different continents allow us to scale the PD to suit the worlds need. We will get a decent slice of potentially billions, as opposed to the majority share of "only" millions
And that just PD. BT, skintrustclub and labskin are all well positioned to become behemoths in their own right.
The next 6 months or so will be massive for the future of this company. All imo of course, but i am very confident :-)